Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_provenance.
• NP926008.RAW3hY9O1qEDsvnTwb3uWx-LsPueNsZHr3c-6fNPTPYB4130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926008.RAW3hY9O1qEDsvnTwb3uWx-LsPueNsZHr3c-6fNPTPYB4130_provenance.
• NP926928.RAS61lEVdDrnyxB6p2G7wQCq6FN5WxzpcPjmxVN8LG0eE130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926928.RAS61lEVdDrnyxB6p2G7wQCq6FN5WxzpcPjmxVN8LG0eE130_provenance.
• NP830156.RAkbOjFWc9jkp_1Oz4o_xRcdWec3L_ajCE3FdCcWd0m3s130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830156.RAkbOjFWc9jkp_1Oz4o_xRcdWec3L_ajCE3FdCcWd0m3s130_provenance.
• NP521559.RAf0bNhbAlbypT4LOVLshWhBpPvjWGE39ACaEZ_SZJr3A130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521559.RAf0bNhbAlbypT4LOVLshWhBpPvjWGE39ACaEZ_SZJr3A130_provenance.
• assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP717681.RA_wUAC-6_qVJ1Dz-eoqWFTtxNudqGifS5yVEBkeKmybA130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717681.RA_wUAC-6_qVJ1Dz-eoqWFTtxNudqGifS5yVEBkeKmybA130_provenance.
• NP1011030.RAX7eMEiwufMW0E4qIlsrFoEohjaPNHun-VB8DjDDfDLM130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1011030.RAX7eMEiwufMW0E4qIlsrFoEohjaPNHun-VB8DjDDfDLM130_provenance.
• assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP902327.RAISyTo51oicEhlbIUAKuNF5T1_EEygmrJvbEt1eFA-ic130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902327.RAISyTo51oicEhlbIUAKuNF5T1_EEygmrJvbEt1eFA-ic130_provenance.
• NP731992.RAcnwsAnMDwlVZW9HTbtM7WDgePgTv3YktZ-DnM9ztH4U130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731992.RAcnwsAnMDwlVZW9HTbtM7WDgePgTv3YktZ-DnM9ztH4U130_provenance.
• NP731995.RAZ80SUKimuoD9Dh8MUrte4KCi-RVAZLHgLSFLHDMpk2w130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731995.RAZ80SUKimuoD9Dh8MUrte4KCi-RVAZLHgLSFLHDMpk2w130_provenance.
• NP731997.RAbIPI0DhrKrMq_WUbLYehZi0GIB8SU0NdeaYpBYUq69g130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731997.RAbIPI0DhrKrMq_WUbLYehZi0GIB8SU0NdeaYpBYUq69g130_provenance.
• assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP527254.RABOfiDPJW5kiJ-MUnZRFeE9PVkBDVt0FB1vGwzB3u4zA130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527254.RABOfiDPJW5kiJ-MUnZRFeE9PVkBDVt0FB1vGwzB3u4zA130_provenance.
• NP423518.RA0pcB_B95VXlvoI6rbTg9pEtZwaM8fHMsn3Le6wiey5c130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423518.RA0pcB_B95VXlvoI6rbTg9pEtZwaM8fHMsn3Le6wiey5c130_provenance.
• NP1005591.RAP4h7728RSEqSr6o64ZDSgJk8t66CDlGy7-ISKbR4mSY130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005591.RAP4h7728RSEqSr6o64ZDSgJk8t66CDlGy7-ISKbR4mSY130_provenance.
• NP1009564.RAM92PWZPZov2jyi1LqwBOk2m2cW0oXIh_TvedhG5cXuQ130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009564.RAM92PWZPZov2jyi1LqwBOk2m2cW0oXIh_TvedhG5cXuQ130_provenance.
• NP1010232.RAKWKk97zSOvVOgSg03Ihkza-Ykhrtb8uLEQVUHvfsW1s130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010232.RAKWKk97zSOvVOgSg03Ihkza-Ykhrtb8uLEQVUHvfsW1s130_provenance.
• NP731993.RA0J-v9MEEqMdfsf9x4XYAonB30PglJ8qTR7cMM1XMfss130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731993.RA0J-v9MEEqMdfsf9x4XYAonB30PglJ8qTR7cMM1XMfss130_provenance.
• NP731994.RA_XAu-cMQudDciHON7hIRCKp3h2YmxZ_id1sjWwIozVI130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731994.RA_XAu-cMQudDciHON7hIRCKp3h2YmxZ_id1sjWwIozVI130_provenance.
• NP731996.RAzag8sMzV-j9m8nxC6IWhEZ9-tTtKq6tyxzSzlRnquVg130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731996.RAzag8sMzV-j9m8nxC6IWhEZ9-tTtKq6tyxzSzlRnquVg130_provenance.